No Result
View All Result
  • Login
Thursday, October 16, 2025
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Economy

Why The Canadian Govt And Big Pharma Are Waging War On An Ostridge Farm

by FeeOnlyNews.com
5 months ago
in Economy
Reading Time: 5 mins read
A A
0
Why The Canadian Govt And Big Pharma Are Waging War On An Ostridge Farm
Share on FacebookShare on TwitterShare on LInkedIn


??LISTEN TO THIS CLIP AND TELL ME THE ATTEPTED OSTRICH CULLING ISN’T THE VACCINE INDUSTRY TRYING TO WIPE OUT COMPETITION?? pic.twitter.com/GYODt61mnO

— Kyle Kemper ? (@kylekemper) May 16, 2025

Post by AgentGuru on X:

Canada’s Ostrich Cull Scandal: Are Big Pharma and Globalist Interests Pulling the Strings?When I first heard about the ostrich farm in Edgewood, British Columbia, facing a forced cull of 400 ostriches, something immediately felt off. Sure, authorities claim they’re responding to an avian flu outbreak—but the deeper I dig into this, the more it smells of something else entirely. Let’s get right into it, because this isn’t just about bird flu—this is about science, censorship, profits, and powerful global interests that seem determined to control the narrative and crush alternatives.

The Edgewood Ostrich Outrage: How We Got Here

Picture a remote, idyllic farm in British Columbia’s Kootenay region, home to about 400 ostriches on 65 acres. On December 31, 2024, two ostriches tragically die of H5N1 avian flu, reportedly brought by wild migratory birds. This leads to a swift quarantine by the Canadian Food Inspection Agency (CFIA)—but that’s just the beginning.

Incredibly, after the initial outbreak, only about 40 birds (roughly 10% of the flock, mainly younger ostriches) succumb to the virus. Within just days, something remarkable occurs: the flock stabilizes, and the remaining 90% of the birds are thriving. Farm owner Karen Espersen observes that these ostriches seem to develop immunity, something clearly special and scientifically fascinating.

Yet despite the farm’s desperate pleas for additional testing and careful scientific study, the CFIA orders all ostriches culled—every last healthy bird—to supposedly “prevent the spread.” The family fights back, but on May 13, 2025, the Canadian Federal Court sides with the CFIA, leaving no room for appeal. The ostriches, despite clear evidence of recovery and possible immunity, are condemned to death.

Why the rush to destroy animals that might be holding keys to groundbreaking treatments? Why no interest in studying them further?

Ostrich Eggs and Antibodies: A Game-Changing Threat to Big Pharma?Here’s where it gets interesting. Ostriches aren’t just giant flightless birds—they are potent biological factories. Their eggs contain powerful antibodies that have already demonstrated incredible therapeutic potential. Each ostrich egg can yield as many antibodies as 100 chicken eggs or 800 rabbits. That’s not just impressive, it’s potentially disruptive to the pharmaceutical industry.

Dr. Yasuhiro Tsukamoto (nicknamed “Dr. Ostrich”), a prominent Japanese veterinary immunologist, has been leading pioneering research using ostrich antibodies. His work, in collaboration with the Edgewood farm, produced breakthrough products during the COVID-19 crisis, including masks and nasal sprays coated with ostrich antibodies that neutralize viruses effectively. Hospitals in Japan even ran successful clinical trials using ostrich antibody nasal sprays for virus prevention.

Now, apply this logic to avian flu—a virus global health authorities (including the WHO and World Economic Forum) are increasingly hyping as “the next COVID,” predicting global outbreaks and calling for new mass vaccination programs. If ostrich antibodies could provide effective natural immunity or treatment against bird flu, that could render new vaccines—particularly expensive, patented mRNA vaccines—unnecessary or less profitable.

It’s not a stretch to see why pharmaceutical giants might perceive ostrich antibodies as a direct threat: cheap, natural, effective, and impossible to monopolize like lab-engineered vaccines.

The Pharma Connection: Is Big Money Silencing Alternative Solutions?As I researched deeper, disturbing questions arose. According to the ostrich farm owners, CFIA officials bizarrely grilled them about their proprietary antibody research during quarantine meetings—unusual questioning, to say the least, for an agency supposedly just concerned with containment. Why was a regulatory agency suddenly so interested in proprietary intellectual property?

From my perspective, this screams of corporate influence—exactly the type of “public-private partnership” favored by groups like the World Economic Forum, where regulatory agencies and pharmaceutical interests often blend seamlessly.

Indeed, ostrich antibodies represent precisely the kind of “inconvenient science” that Big Pharma—and powerful globalist institutions like the WHO and WEF—would rather not let flourish. After all, if a farmer in British Columbia could produce inexpensive antibody-based solutions to avian flu, COVID, or other pandemics, why would governments invest billions in patented mRNA technologies championed by the pharmaceutical establishment?

This dynamic mirrors precisely what we’ve seen throughout COVID: affordable, natural solutions systematically sidelined in favor of profitable, patent-protected vaccines and treatments. And let’s be honest—the upcoming bird flu “crisis” narrative feels suspiciously similar to the lead-up to the COVID pandemic: a hyped-up global threat, new vaccines in the pipeline, and massive profits at stake.

A Pattern of Suppression: “Trust the Science”…or Else?Critically, the CFIA’s rigid refusal to even consider alternative solutions or studies of these potentially immune birds exposes a deeper pattern of institutional inflexibility—or intentional suppression. Despite the farm’s strict quarantine, remote location, and documented immunity of surviving birds, authorities refused any meaningful investigation or testing, stubbornly adhering to blanket policies that conveniently shut down independent science.

Even respected veterinarians like Dr. Scott Weese from the University of Guelph have pointed out the irrationality: “We’re not eradicating H5N1 by culling these ostriches,” he said plainly. Premier David Eby of British Columbia even questioned why there’s no “case-by-case” flexibility, expressing frustration at the CFIA’s blanket policy.

Yet the authorities wouldn’t budge an inch. The message is clear: “Trust our science, no questions allowed.”

Public Outrage and the Fight for TruthThe outrage from the farm, community, and global observers has been intense. Activists and animal advocates descended on Edgewood, physically trying to block the cull and livestreaming desperate pleas for help. Even Robert F. Kennedy Jr., known for challenging the COVID vaccine narrative, weighed in, calling the planned ostrich cull “horrifying.”

The farm’s supporters—and I count myself among them—see this cull as part of a larger pattern: global health authorities and big-money pharmaceutical interests systematically suppressing any inexpensive, natural, and non-patentable solutions. The ostrich antibodies represent exactly the kind of disruptive innovation that global elites, aligned with pharma profits and pandemic narratives, want silenced.

Coincidence or Conspiracy? The Bigger Picture EmergesIs it mere coincidence that, just as ostrich antibodies were demonstrating real promise as inexpensive, natural antiviral solutions, Canadian authorities swiftly moved to destroy the birds producing them?

While no court case or official inquiry directly proves Big Pharma influence on CFIA’s decision, context matters greatly. The aggressive stance of global health organizations promoting the avian flu as “the next big threat,” coupled with heavy investment in mRNA vaccine technology, makes ostrich-derived natural immunity research deeply inconvenient. Powerful financial interests would clearly benefit from removing such competition.

Even Canadian MLAs and animal-rights advocates are questioning whether something darker lies behind this incident. It may not be outright conspiracy—though that can’t be ruled out—but rather the structural, systemic alignment between big-money pharmaceutical interests, compliant government agencies, and international globalist institutions promoting centralized pandemic responses.

Looking Ahead: Fighting for Transparency and Real ScienceThis ostrich farm incident isn’t just another animal culling. It’s a symptom of a broader struggle—science versus profit, freedom versus control, transparency versus censorship.

We have an opportunity to push back, demanding full transparency from government and health authorities. We must insist on fair, unbiased scientific inquiry into promising alternatives, no matter how disruptive they may be to established financial or political interests.

Imagine if Canadian authorities had paused to thoroughly investigate these ostriches’ apparent immunity. Imagine a world where inexpensive, effective ostrich antibodies became a mainstream, natural alternative to costly pharmaceutical vaccines. Unfortunately, this scenario directly threatens too many entrenched interests to be allowed to develop without resistance.

We can’t allow powerful actors to squash independent innovation under the guise of “public health.” The Edgewood ostrich cull should be a wake-up call: it’s about far more than birds—it’s about the future of medical freedom, scientific transparency, and resisting the weaponization of fear-based pandemic narratives for profit and control.

Let’s keep our eyes wide open—and keep digging.





Source link

Tags: bigCanadianFarmGovtOstridgePharmaWagingWar
ShareTweetShare
Previous Post

CME Group set to launch XRP futures on Monday amid legal setback for SEC and Ripple

Next Post

Trump Shrugs Off Netanyahu on Gulf Tour

Related Posts

What Does New High in US Stock Market Margin Debt Portend?

What Does New High in US Stock Market Margin Debt Portend?

by FeeOnlyNews.com
October 16, 2025
0

Your truly is not keen about having to think as much about stock market price levels as seems warranted of...

Switzerland slashes GDP forecast as Trump’s tariffs weigh on economy

Switzerland slashes GDP forecast as Trump’s tariffs weigh on economy

by FeeOnlyNews.com
October 16, 2025
0

Untere Schleuse wooden bridge in Thun, Switzerland.Education Images | Universal Images Group | Getty ImagesSwitzerland's government on Thursday cut its...

China Retaliates Over Dutch Nexperia Seizure

China Retaliates Over Dutch Nexperia Seizure

by FeeOnlyNews.com
October 16, 2025
0

The Dutch government believed it could prevent China from stealing “crucial technological knowledge” by seizing a private semiconductor company, Nexperia....

Zelensky – The NeoNatzi Frontman

Zelensky – The NeoNatzi Frontman

by FeeOnlyNews.com
October 15, 2025
0

  QUESTION: You believe that Zelensky impedes peace with Russia? GB ANSWER: Of course, Zelensky, I believe, is a NeoNazi and...

Wells Fargo, Pfizer CEOs warn U.S. could lose out to China without innovation

Wells Fargo, Pfizer CEOs warn U.S. could lose out to China without innovation

by FeeOnlyNews.com
October 15, 2025
0

Albert Bourla, CEO of Pfizer, Charlie Scharf, Wells Fargo & Company CEO and Kathy Warden, Northrop Grumman Chair & CEO...

Trump Trio of Vought, Miller, and Eric Rise From the Muck

Trump Trio of Vought, Miller, and Eric Rise From the Muck

by FeeOnlyNews.com
October 15, 2025
0

A dominant Trump trio stood out in the news this week: Russell Vought who is gutting the federal bureaucracy; Stephen...

Next Post
Trump Shrugs Off Netanyahu on Gulf Tour

Trump Shrugs Off Netanyahu on Gulf Tour

Breakout Stocks: How to trade Mazagon Dock, Bharat Dynamics & Bharat Electronics that hit fresh 52-week high? – Market Summary

Breakout Stocks: How to trade Mazagon Dock, Bharat Dynamics & Bharat Electronics that hit fresh 52-week high? - Market Summary

  • Trending
  • Comments
  • Latest
Bitcoin: Breakout Above 7K Resistance Could Unlock Fresh Upside

Bitcoin: Breakout Above $117K Resistance Could Unlock Fresh Upside

September 19, 2025
AB Infrabuild, among 5 cos to approach record date for stock splits. Last day to buy for eligibility

AB Infrabuild, among 5 cos to approach record date for stock splits. Last day to buy for eligibility

October 15, 2025
Housing Market Loses Steam, “National Buyer’s Market” Likely in 2026

Housing Market Loses Steam, “National Buyer’s Market” Likely in 2026

October 14, 2025
Are You Losing Out Because of Medicare Open Enrollment Mistakes?

Are You Losing Out Because of Medicare Open Enrollment Mistakes?

October 13, 2025
Coinbase boosts investment in India’s CoinDCX, valuing exchange at .45B

Coinbase boosts investment in India’s CoinDCX, valuing exchange at $2.45B

October 15, 2025
Government shutdown could drain financial advisor optimism

Government shutdown could drain financial advisor optimism

October 7, 2025
Treasury again takes aim at advanced training funds

Treasury again takes aim at advanced training funds

0
Suze Orman on Why Claiming Social Security Early Is a Bad Idea

Suze Orman on Why Claiming Social Security Early Is a Bad Idea

0
Best money market account rates today, October 15, 2025 (secure up to 4.26% APY)

Best money market account rates today, October 15, 2025 (secure up to 4.26% APY)

0
IPO-bound Groww launches commodities trading services on platform

IPO-bound Groww launches commodities trading services on platform

0
What You Should Know About Alzheimer’s Early Warning Signs

What You Should Know About Alzheimer’s Early Warning Signs

0
Taiwan Semiconductor (TSM): KI-Boom treibt Chip-Giganten an die Breakout-Schwelle!

Taiwan Semiconductor (TSM): KI-Boom treibt Chip-Giganten an die Breakout-Schwelle!

0
Suze Orman on Why Claiming Social Security Early Is a Bad Idea

Suze Orman on Why Claiming Social Security Early Is a Bad Idea

October 16, 2025
Ripple Makes B Bet on Corporate Treasury Payments With GTreasury Acquisition Deal

Ripple Makes $1B Bet on Corporate Treasury Payments With GTreasury Acquisition Deal

October 16, 2025
Austin Delta Sky Club Review: Small, But Good Food

Austin Delta Sky Club Review: Small, But Good Food

October 16, 2025
Bny Mellon outlines 12% full year net interest income growth target while advancing commercial model and digital asset initiatives (NYSE:BK)

Bny Mellon outlines 12% full year net interest income growth target while advancing commercial model and digital asset initiatives (NYSE:BK)

October 16, 2025
BlackRock’s crypto push deepens with a retooled product to serve stablecoin issuers

BlackRock’s crypto push deepens with a retooled product to serve stablecoin issuers

October 16, 2025
A new wave of social media apps provide hope in a doomscrolling world 

A new wave of social media apps provide hope in a doomscrolling world 

October 16, 2025
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Suze Orman on Why Claiming Social Security Early Is a Bad Idea
  • Ripple Makes $1B Bet on Corporate Treasury Payments With GTreasury Acquisition Deal
  • Austin Delta Sky Club Review: Small, But Good Food
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.